NCT04540588 2025-12-02Retreatment With Intratumoral Diffusing Alpha Radiation EmittersAlpha Tau Medical LTD.Phase NA Completed2 enrolled
NCT03422536 2024-09-04Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell CarcinomaUniversity of ArizonaPhase 2 Completed78 enrolled 16 charts
NCT03602079 2023-08-03Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 GeneKlus Pharma Inc.Phase 1/2 Completed49 enrolled
NCT00050388 2008-06-24Phase II Trial of Allovectin-7® for Head and Neck CancerVicalPhase 3 Completed